Cargando…
Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation
Background: Alzheimer's disease (AD) is the major cause of dementia in population aged over 65 years, accounting up to 70% dementia cases. However, validated peripheral biomarkers for AD diagnosis are not available up to present. In this study, we adopted a new strategy of combination of comput...
Autores principales: | Yao, Fang, Zhang, Kaoyuan, Zhang, Yan, Guo, Yi, Li, Aidong, Xiao, Shifeng, Liu, Qiong, Shen, Liming, Ni, Jiazuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331438/ https://www.ncbi.nlm.nih.gov/pubmed/30671019 http://dx.doi.org/10.3389/fneur.2018.01158 |
Ejemplares similares
-
Protein Biomarkers of Autism Spectrum Disorder Identified by Computational and Experimental Methods
por: Yao, Fang, et al.
Publicado: (2021) -
Phosphoproteomic Profiling of Selenate-Treated Alzheimer's Disease Model Cells
por: Chen, Ping, et al.
Publicado: (2014) -
In silico identification of the sea squirt selenoproteome
por: Jiang, Liang, et al.
Publicado: (2010) -
Correlation of blood–brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease
por: Cheng, Zhaozhao, et al.
Publicado: (2023) -
Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer’s Disease Mice
por: Shen, Liming, et al.
Publicado: (2016)